ewrobbins.com

User Tools

Site Tools

You are here: start » resources » research » leads
resources:research:leads

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
resources:research:leads [2025/02/11 14:21] – [FAPi Scans] adminresources:research:leads [2026/03/11 08:31] (current) – [Outside Institutions] admin
Line 1: Line 1:
 +===== Outside Institutions =====
 +  * [[https://reporter.nih.gov/search/8Zd8KlnZjkOzJZo5POhsSg/project-details/11193816 | PENN: JOHNSON, CHEILONDA]]
 +  * [[https://reporter.nih.gov/search/Udp83l3pmEuCJZmReu84kw/project-details/11112549 | VANDERBILT: WILFONG, ERIN M]]
 +  * [[ | UCLA: BAE, SANGMEE]]
 +  * [[https://reporter.nih.gov/search/-rJ6-9OHKki8b6uLuaZ5nQ/project-details/11199890#description | UCLA: VOLKMAN, ELIZABETH]]
 +
 +===== Myositis Clinical Trials Consortium =====
 +  * [[https://myositisclinicaltrialsconsortium.org]]
 +
 +===== Secondary Data Analysis ====
 +  * [[https://datatools.ahrq.gov/]]
 +
 +
 +===== MDA5 =====
 +  * **Kyoto University group**
 +    * famous for [[https://doi.org/10.1002/art.41105 | pred + tacro + CYC for RP-ILD a/w MDA5]]
 +    * important names:
 +      * Ran Nakashima
 +      * Tsuneyo Mimori 
 +  * **Chiba University**
 +    * [[https://doi.org/10.1136/rmdopen-2022-002795 | Tofacitinib for refractory MDA5]]
 ====== FAPi Scans ====== ====== FAPi Scans ======
  
 +  * [[https://doi.org/10.1148/radiol.220749 | Review: FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease]]
   * [[https://doi.org/10.1038/s44303-024-00053-z | Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)]]   * [[https://doi.org/10.1038/s44303-024-00053-z | Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)]]
   * [[https://doi.org/10.1007/s00259-023-06564-y | Initial results with [$^{18}$F]FAPI-74 PET/CT in idiopathic pulmonary fibrosis]]   * [[https://doi.org/10.1007/s00259-023-06564-y | Initial results with [$^{18}$F]FAPI-74 PET/CT in idiopathic pulmonary fibrosis]]
   * [[https://doi.org/10.2967/jnumed.121.261925 | Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study]]   * [[https://doi.org/10.2967/jnumed.121.261925 | Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study]]
 +  * [[https://doi.org/10.1016/s2665-9913(20)30421-5 | FAPI in SSC-ILD]]
 +  * [[https://doi.org/10.1164/rccm.202110-2414oc | Comprehensive Analysis of Fibroblast Activation Protein Expression in Interstitial Lung Diseases]]
  
 ====== SOMA Scans ====== ====== SOMA Scans ======
Line 11: Line 35:
  
  
 +  * [[https://doi.org/10.1164/rccm.202109-2106OC | SomaScan in PAH]]
   * [[https://doi.org/10.1101/2024.07.11.24310161]]   * [[https://doi.org/10.1101/2024.07.11.24310161]]
   * [[http://doi.org/10.1021/acs.jproteome.4c00411]]   * [[http://doi.org/10.1021/acs.jproteome.4c00411]]
resources/research/leads.1739283689.txt.gz · Last modified: by admin

Page Tools

Except where otherwise noted, content on this wiki is licensed under the following license: CC Attribution-Share Alike 4.0 International
CC Attribution-Share Alike 4.0 International Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki